Riskpilot← Back to searchSign inGet full accessSe & Arbeta AB
ABActiveOrg 5567867618Göteborgsvägen 32Retail sale of medical and orthopaedic goods · NACE 4774Est. 20090 employees
Revenue 2024
SEK 3,7M
-4% vs 2023
EBITDA margin
9.1%
-42% vs 2023
Equity ratio
64.2%
Financial strength
Net profit 2024
SEK 210K
-49% vs 2023
| Revenue | SEK 3,7M | -4% |
| EBITDA | SEK 339K | -42% |
| Net profit | SEK 210K | -49% |
| Total assets | SEK 1,9M | -1% |
| Equity | SEK 1,2M | +21% |
| Employees | 0 | — |
Legal name
Se & Arbeta AB
Org number
5567867618
Legal form
Aktiebolag
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
11 augusti 2009
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolagets verksamhet ska vara att bedriva handel med bågar, reservdelar, glas, kontaktlinser, förstoringsglas, belysning samt service- och konsultverksamhet därmed inom ögon- och synområde, ävensom bemanningstjänster till optikerbutik samt äga, förvalta och idka handel med fastigheter och värdepapper samt därmed förenlig verksamhet.
Address
Göteborgsvägen 32
Email
carina.e.olsson@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 716 | 3 944 | 3 954 | 3 896 | 3 732 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 513 | 837 | 483 | 580 | 339 |
| Depreciation & amort. | −41 | −65 | −65 | −65 | −65 |
| EBIT | 472 | 772 | 418 | 515 | 274 |
| Net financials | −4 | −11 | −7 | 6 | −2 |
| Profit before tax | 347 | 571 | 411 | 521 | 272 |
| Tax | −78 | −121 | −88 | −108 | −62 |
| Net profit | 269 | 450 | 323 | 413 | 210 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 367 | 2 294 | 2 252 | 1 868 | 1 850 |
| Equity | 671 | 1 041 | 1 164 | 977 | 1 187 |
| Long-term debt | 41 | 253 | 47 | 13 | 0 |
| Short-term debt | 465 | 620 | 661 | 498 | 283 |
| Total debt | 506 | 873 | 708 | 511 | 283 |
EBITDA margin
9.1%
This company
15.8%
Market median
-42% vs market
20202024
Equity ratio
64.2%
This company
38.2%
Market median
+68% vs market
20202024
Return on equity
17.7%
This company
18.4%
Market median
+4% vs market
20202024
Net profit margin
5.6%
This company
8.1%
Market median
-31% vs market
20202024
Asset turnover
2.02×
This company
1.12×
Market median
+80% vs market
20202024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Se & Arbeta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carina Elisabeth Olsson | Board of Directors | 0 companies |
| Lars Jörgen Olsson | Deputy Board Member | 0 companies |